Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2011
The mouse lymphoma assayMelvyn Lloyd, Darren KiddMutagenesis|October 24, 2024
Industrial Genotoxicology Group: 36th Annual Meeting ReportDarren Kidd, Ian Crooks, Angela Saccardo, et al.Regulatory Toxicology and Pharmacology : RTP|October 15, 2025
Evaluating the ability of defined approaches to predict the human skin sensitisation potential of chemicals previously untested in new approach methodologiesMartyn L Chilton, Tasha Jones, Adrian Fowkes, et al.Education for Primary Care : an Official Publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors|August 31, 2016
Moving into the 'patient-centred medical home': reforming Australian general practicePaul Hayes, Anthony Lynch, Jenni StiffeMutagenesis|December 17, 2013
Where will genetic toxicology testing be in 30 years' time? Summary report of the 25th Industrial Genotoxicity Group Meeting, Royal Society of Medicine, London, November 9, 2011Patricia Ellis, Paul Fowler, Ewan Booth, et al.Mutagenesis|December 4, 2019
The 3D reconstructed skin micronucleus assay: considerations for optimal protocol designDarren Kidd, Sarah Phillips, Teresa Chirom, et al.Mutation Research. Genetic Toxicology and Environmental Mutagenesis|March 5, 2025
A comparative analysis of select P450 enzymes in uninduced and PB/BNF-induced hamster and rat liver S9Kristie Evans, Slaydon Boitnotte, Errol Zeiger, et al.Journal of Psychosocial Nursing and Mental Health Services|August 9, 2008
Assessment and management of hospitalized suicidal patientsMark Anthony Lynch, Patricia B Howard, Peggy El-Mallakh, et al.Mutation Research|March 2, 2011
Evaluation of a multi-endpoint assay in rats, combining the bone-marrow micronucleus test, the Comet assay and the flow-cytometric peripheral blood micronucleus testDamian E Bowen, James H Whitwell, Lucinda Lillford, et al.Mutagenesis|July 4, 2003
Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicityAnthony Lynch, James Harvey, Michael Aylott, et al.Pageof 3